Featured Posts
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Op-Eds
Animal Rights, Human Wrongs
Animal rights extremism—which the FBI has labeled the biggest domestic terrorism threat—has encountered a number of serious reverses recently. These reverses are a…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. TECHNOLOGY Chinese President Hu Jintao visits Washington State and meets with Microsoft…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. LEGAL Payments from tobacco companies to states are found to have been diverted away…
Newsletter
The Competitive Enterprise Institute Daily Update
1. TELEVISION TV networks challenge the Federal Communications Commission’s indecency fines in court. CEI Expert Available to Comment: Vice President for…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. FINANCE An adviser to the Securities and Exchange Commission suggests that the SEC will be receptive…
Op-Eds
Twenty Years After Chernobyl
April 26 marks the 20th anniversary of the accident at the Chernobyl nuclear power plant. Anti-nuclear activists are still trying to turn Chernobyl into…